☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Equillium
Equillium Reports Initiation of P-III (EQUATOR) Study for Itolizumab as 1L Treatment of Acute Graft-Versus-Host Disease
March 7, 2022
PharmaShots Weekly Snapshot (December 09-13, 2019)
December 16, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.
